APA
Dal Lago L., Durbecq V., Desmedt C., Salgado R., Verjat T., Lespagnard L., Ma Y., Veys I., Di Leo A., Sotiriou C., Piccart M. & Larsimont D. (20070130). Correction for chromosome-17 is critical for the determination of true Her-2/neu gene amplification status in breast cancer. : Molecular cancer therapeutics.
Chicago
Dal Lago Lissandra, Durbecq Virginie, Desmedt Christine, Salgado Roberto, Verjat Thibault, Lespagnard Laurence, Ma Yan, Veys Isabelle, Di Leo Angelo, Sotiriou Christos, Piccart Martine and Larsimont Denis. 20070130. Correction for chromosome-17 is critical for the determination of true Her-2/neu gene amplification status in breast cancer. : Molecular cancer therapeutics.
Harvard
Dal Lago L., Durbecq V., Desmedt C., Salgado R., Verjat T., Lespagnard L., Ma Y., Veys I., Di Leo A., Sotiriou C., Piccart M. and Larsimont D. (20070130). Correction for chromosome-17 is critical for the determination of true Her-2/neu gene amplification status in breast cancer. : Molecular cancer therapeutics.
MLA
Dal Lago Lissandra, Durbecq Virginie, Desmedt Christine, Salgado Roberto, Verjat Thibault, Lespagnard Laurence, Ma Yan, Veys Isabelle, Di Leo Angelo, Sotiriou Christos, Piccart Martine and Larsimont Denis. Correction for chromosome-17 is critical for the determination of true Her-2/neu gene amplification status in breast cancer. : Molecular cancer therapeutics. 20070130.